(News Bulletin 247) – A clearly affirmed upward momentum on the NEURONES share will invite active investors to position themselves for the purchase, within the framework of a swing trading operation.

NB: investors who have followed our recommendation dated 06/12/22 on this same dossier may keep the position, taking care to adjust the stop loss and the price target according to the present elements.

KEY GRAPHIC ELEMENTS

Since the October 13 rebalancing doji, the bullish momentum has strengthened in the stock, with no detectable signs of waning. The record continues to rise above a 20-day moving average (in dark blue) which acts as chart support. Closings occur regularly on session highs, and consolidations are healthy and short.

FORECAST

In view of the key chart factors that we have mentioned, our opinion is bullish on NEURONES stock in the short term.

Active investors will take a buying position on the NEURONES share price at €42,650 with a target of €49,950 in sight. They will protect their capital by placing a stop at €39,990.

The News Bulletin 247 board

NEURONS
Positive €42,650
Objective :
49.950 €
Potential :
+17.12%
Stop:
39.990 €
Resistance(s):
45,000 / 50,000
Medium(s):
40,000 / 37,100 / 36,000

CHART IN DAILY DATA

Graphic made from the software Prorealtime



function creatOutbrainJs() {
const creatJs = document.createElement(“script”);
creatJs.defer = true;
creatJs.src = “https://widgets.outbrain.com/outbrain.js”;
return document.body.appendChild(creatJs);
}

window.didomiOnReady = window.didomiOnReady || [];

window.didomiOnReady.push(function(Didomi) {
console.log(“Didomi ready “);

Didomi.getObservableOnUserConsentStatusForVendor(164)
.filter(function (status) { return status !== undefined })
.subscribe(function(consentStatus) {
if (consentStatus === false || consentStatus === true) {
console.log(“Didomi consent -> exécution du script outbrain “, consentStatus);
creatOutbrainJs()
}
});

});